Can Dietary Supplements Improve Inflammatory Biomarkers and Clinical Symptoms in Migraine? A Narrative Review
Abstract
This narrative review examines the extent to which non-pharmacological dietary supplements influence inflammatory and oxidative pathways in migraine and how these changes translate to clinical improvements. A total of 26 clinical trials published up to May 2025 were included, focusing on omega-3 fatty acids, curcumin, coenzyme Q10 (CoQ10), alpha-lipoic acid (ALA), vitamin D, selenium, zinc, and probiotics. These compounds modulated cytokine production, reduced oxidative markers, and enhanced antioxidant defenses. Clinical outcomes—including headache frequency, severity, and duration—improved across studies, even in individuals with mild baseline inflammation, highlighting subclinical processes. Combination approaches with multiple agents showed greater efficacy in biochemical and clinical parameters. Gut–brain axis interventions (probiotics/prebiotics) yielded promising but variable results. Targeted dietary and bioactive interventions appear to improve migraine outcomes by modulating inflammatory and oxidative mechanisms. Their consistent clinical benefits support their potential as adjunctive strategies alongside standard pharmacological treatments.
Related
- Effects of Mobilization with Movement Versus Sham Mobilization on Inflammatory Biomarkers and Clinical Outcomes in Patients with Knee Osteoarthritis: A Randomized Double-Blind Clinical Trial
- Chronic Occupational Stress and Immune–Inflammatory Dysregulation: Mechanisms, Clinical Consequences, Biomarkers and Implications for Occupational Medicine
- Frontal Cerebral Blood Flow Deficits in Behavioral Variant Frontotemporal Dementia: Associations With Clinical Symptoms, Peripheral Vascular Biomarkers, and Neuroimaging Measures.
- Nutraceuticals and Metabolic Health: Can Supplements Prevent Metabolic Syndrome? A Narrative Review
- Observed Clinical and Operational Factors Are Associated with Biomarker Test Utilization in Respiratory Virus RT-PCR Testing: A Real-World Analysis of Inflammatory, Cardiac, and Thrombotic Biomarkers.
BibTeX
@article{nohegari2026dietary,
title = {{Can Dietary Supplements Improve Inflammatory Biomarkers and Clinical Symptoms in Migraine? A Narrative Review}},
author = {Maryam Nohegari and Mohammadreza Vafa},
journal = {International Journal of Preventive Medicine},
year = {2026},
month = sep,
doi = {10.4103/ijpvm.ijpvm_396_25},
url = {https://doi.org/10.4103/ijpvm.ijpvm_396_25},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Can Dietary Supplements Improve Inflammatory Biomarkers and Clinical Symptoms in Migraine? A Narrative Review
AU - Maryam Nohegari
AU - Mohammadreza Vafa
PY - 2026
DA - 2026/09/01
JO - International Journal of Preventive Medicine
DO - 10.4103/ijpvm.ijpvm_396_25
UR - https://doi.org/10.4103/ijpvm.ijpvm_396_25
AB - This narrative review examines the extent to which non-pharmacological dietary supplements influence inflammatory and oxidative pathways in migraine and how these changes translate to clinical improvements. A total of 26 clinical trials published up to May 2025 were included, focusing on omega-3 fatty acids, curcumin, coenzyme Q10 (CoQ10), alpha-lipoic acid (ALA), vitamin D, selenium, zinc, and probiotics. These compounds modulated cytokine production, reduced oxidative markers, and enhanced antioxidant defenses. Clinical outcomes—including headache frequency, severity, and duration—improved across studies, even in individuals with mild baseline inflammation, highlighting subclinical processes. Combination approaches with multiple agents showed greater efficacy in biochemical and clinical parameters. Gut–brain axis interventions (probiotics/prebiotics) yielded promising but variable results. Targeted dietary and bioactive interventions appear to improve migraine outcomes by modulating inflammatory and oxidative mechanisms. Their consistent clinical benefits support their potential as adjunctive strategies alongside standard pharmacological treatments.
SN - 2008-7802
SN - 2008-8213
ER -